These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10332072)

  • 1. Micronization of drugs using supercritical carbon dioxide.
    Kerc J; Srcic S; Knez Z; Sencar-Bozic P
    Int J Pharm; 1999 May; 182(1):33-9. PubMed ID: 10332072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronization and microencapsulation of felodipine by supercritical carbon dioxide.
    Chiou AH; Cheng HC; Wang DP
    J Microencapsul; 2006 May; 23(3):265-76. PubMed ID: 16801239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation.
    Pestieau A; Krier F; Lebrun P; Brouwers A; Streel B; Evrard B
    Int J Pharm; 2015 May; 485(1-2):295-305. PubMed ID: 25796121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.
    Cha KH; Cho KJ; Kim MS; Kim JS; Park HJ; Park J; Cho W; Park JS; Hwang SJ
    Int J Nanomedicine; 2012; 7():5565-75. PubMed ID: 23118538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide.
    Sanganwar GP; Gupta RB
    Int J Pharm; 2008 Aug; 360(1-2):213-8. PubMed ID: 18550302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.
    Bouledjouidja A; Masmoudi Y; Van Speybroeck M; Schueller L; Badens E
    Int J Pharm; 2016 Feb; 499(1-2):1-9. PubMed ID: 26732521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
    Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
    Cho YD; Park YJ
    Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG
    Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
    Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
    Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of felodipine nanosuspension.
    Sahu BP; Das MK
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):183-93. PubMed ID: 24198215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
    Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.
    Buch P; Langguth P; Kataoka M; Yamashita S
    J Pharm Sci; 2009 Jun; 98(6):2001-9. PubMed ID: 18855916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
    Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
    Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier.
    Alshaikh RA; Essa EA; El Maghraby GM
    Pharm Dev Technol; 2020 Feb; 25(2):168-177. PubMed ID: 31642728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate-released pelletized solid dispersion containing fenofibrate: Formulation, in vitro characterization, and bioequivalence studies in experimental beagle dogs.
    Nguyen CN; Pham CV; Le Thien G; Ngoc BT; Le Thi H; Huyen CPT; Thi TN
    Int J Pharm; 2019 Oct; 570():118661. PubMed ID: 31491482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles.
    Juenemann D; Jantratid E; Wagner C; Reppas C; Vertzoni M; Dressman JB
    Eur J Pharm Biopharm; 2011 Feb; 77(2):257-64. PubMed ID: 21074611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.